Register Login

NOVOCURE LTD (NVCR)

(10% Negative) NOVOCURE LTD (NVCR) Announces Delay in observed Trials for locally Due to Regulatory Process, Manufacturing Considerations, Safety Review

Full text
Register to leave comments
  • News bot June 30, 2026, 11:01 a.m.

    📋 NOVOCURE LTD (NVCR) - Clinical Trial Update

    Filing Date: 2026-06-30

    Accepted: 2026-06-30 07:00:24

    Event Type: Clinical Trial Update

    Event Details:

    NOVOCURE LTD (NVCR) Announces Clinical Trial Update NOVOCURE LTD (NVCR) provided an update on its clinical development programs. Clinical Development Highlights:
    • Drug Program: observed, trial
    • Diseases/Conditions: locally, Optune Pax
    • Clinical Stage: Phase 3
    • Update Type: Trial Timeline Adjustment
    • Primary Factors: Regulatory Process
    • Collaboration: Tumor Treating Fields

    🔬 Clinical Development Pipeline (NOVOCURE LTD):

    Product Type Development Stage Therapeutic Area Source
    Radiotherapy Drug Approved Glioblastoma Multiforme ClinicalTrials.gov
    Paclitaxel Other Phase PHASE1 Ovarian Carcinoma ClinicalTrials.gov
    TTFields Therapy Drug Phase PHASE2 Glioblastoma ClinicalTrials.gov
    Modified GCN+TTF treatment Drug Phase PHASE1 Pancreas Cancer ClinicalTrials.gov
    nab-Paclitaxel Other Phase PHASE1 Pancreatic Adenocarcinoma ClinicalTrials.gov
    Optune System (NovoTTF-200A System, Tumor Treating Fields, TTFields) Other Approved Malignant Glioma ClinicalTrials.gov
    Gemcitabine Other Phase PHASE1 Pancreatic Adenocarcinoma ClinicalTrials.gov
    Platinum based chemotherapy Drug Phase PHASE3 Metastatic Non-small Cell Lung Cancer ClinicalTrials.gov
    Tumor Treating Fields Therapy Drug Phase PHASE2 Extensive Stage Lung Small Cell Carcinoma ClinicalTrials.gov
    Pembrolizumab Other Phase PHASE3 Metastatic Non-small Cell Lung Cancer ClinicalTrials.gov
    NovoTTF-200T Other Phase PHASE3 Metastatic Non-small Cell Lung Cancer ClinicalTrials.gov
    Concurrent Optune and RT followed by Optune System alone Other Approved Malignant Glioma ClinicalTrials.gov
    NovoTTF-200T System Other Phase PHASE1 Adenocarcinoma of Lung ClinicalTrials.gov
    TTFields Other Approved Glioblastoma ClinicalTrials.gov
    Quality-of-Life Assessment Other Approved Extensive Stage Small Cell Lung Carcinoma ClinicalTrials.gov
    NovoTTF-200A Device Device Approved Extensive Stage Small Cell Lung Carcinoma ClinicalTrials.gov
    Tumor Treating Fields (TTF) Therapy Drug Approved Extensive Stage Small Cell Lung Carcinoma ClinicalTrials.gov
    NovoTTF-100A Other Phase PHASE4 Recurrent Glioblastoma Multiforme ClinicalTrials.gov
    NovoTTF-100L(O) Other Phase PHASE1 Ovarian Carcinoma ClinicalTrials.gov
    Best Standard of Care Other Phase PHASE2 1-5 Brain Metastases From Non-Small Cell Lung Cancer ClinicalTrials.gov
    NovoTTF-100A device Device Phase PHASE2 1-5 Brain Metastases From Non-Small Cell Lung Cancer ClinicalTrials.gov
    NovoTTF-100L Other Phase PHASE1 Pancreatic Adenocarcinoma ClinicalTrials.gov
    Carmustine Other Phase PHASE2 Adult Brain Glioblastoma ClinicalTrials.gov
    Bevacizumab Other Phase PHASE2 Adult Brain Glioblastoma ClinicalTrials.gov
    Electric Field Therapy Drug Phase PHASE2 Adult Brain Glioblastoma ClinicalTrials.gov
    Cisplatin or Carboplatin Other Phase PHASE2 Malignant Pleural Mesothelioma ClinicalTrials.gov
    Pemetrexed Other Phase PHASE2 Malignant Pleural Mesothelioma ClinicalTrials.gov
    NovoTTF-100L device Device Phase PHASE2 Malignant Pleural Mesothelioma ClinicalTrials.gov
    Temozolomide Other Approved Glioblastoma Multiforme ClinicalTrials.gov
    NovoTTF-200A Other Approved Glioblastoma Multiforme ClinicalTrials.gov
    Craniectomy Other Phase PHASE1 Glioblastoma ClinicalTrials.gov
    Optune Other Phase PHASE1 Glioblastoma ClinicalTrials.gov
    Optune TTF device Device Approved Central Nervous System Neoplasms, Primary ClinicalTrials.gov
    Wear novoTTF-200A Other Approved Anaplastic Oligodendroglioma ClinicalTrials.gov
    LCR Meter (Brand: Keysight, Serial Number:E498AL) Other Approved Lung Cancer ClinicalTrials.gov
    Carvedilol Other Phase EARLY_PHASE1 Glioblastoma ClinicalTrials.gov
    NovoTTF Other Preclinical Malignant Glioma ClinicalTrials.gov
    TTFields with adjuvant temozolomide Other Phase PHASE2 Astrocytoma, Grade II ClinicalTrials.gov
    Optune(NOVOTTF-100A) Other Approved RECURRENT GLIOBLASTOMA ClinicalTrials.gov
    Ipilimumab Other Phase PHASE2 Melanoma With Brain Metastasis ClinicalTrials.gov
    Nivolumab Other Phase PHASE2 Melanoma With Brain Metastasis ClinicalTrials.gov
    Quality of Life Questionnaires Other Phase PHASE2 Glioblastoma Multiforme ClinicalTrials.gov
    Brain MRI Other Phase PHASE2 Glioblastoma Multiforme ClinicalTrials.gov
    Laboratory biomarker analysis Other Approved Glioblastoma ClinicalTrials.gov
    NovoTTF100A Other Phase PHASE2 Cancer of Brain and Nervous System ClinicalTrials.gov
    NovoTTF200A (Optune) Other Phase PHASE2 Recurrent Glioblastoma ClinicalTrials.gov
    Ipilimumab 1 mg/kg Other Phase PHASE2 Recurrent Glioblastoma ClinicalTrials.gov
    Nivolumab 3 mg/kg Other Phase PHASE2 Recurrent Glioblastoma ClinicalTrials.gov
    Nivolumab 240 mg IV Other Phase PHASE2 Recurrent Glioblastoma ClinicalTrials.gov
    Stereotactic Radiosurgery (SRS) Procedure Approved Brain Metastases ClinicalTrials.gov
    TTFields and SRS Other Phase PHASE2 Glioblastoma Multiforme ClinicalTrials.gov
    Questionnaire Administration Other Phase PHASE2 Extensive Stage Lung Small Cell Carcinoma ClinicalTrials.gov
    Radiation Therapy Drug Phase PHASE1 Glioblastoma ClinicalTrials.gov
    Tumor Treating Fields Other Phase PHASE1 Glioblastoma ClinicalTrials.gov
    Therapeutic Conventional Surgery Procedure Phase EARLY_PHASE1 Borderline Resectable Pancreatic Adenocarcinoma ClinicalTrials.gov
    Oxaliplatin Other Phase EARLY_PHASE1 Borderline Resectable Pancreatic Adenocarcinoma ClinicalTrials.gov
    Leucovorin Calcium Other Phase EARLY_PHASE1 Borderline Resectable Pancreatic Adenocarcinoma ClinicalTrials.gov
    Leucovorin Other Phase EARLY_PHASE1 Borderline Resectable Pancreatic Adenocarcinoma ClinicalTrials.gov
    Irinotecan Hydrochloride Other Phase EARLY_PHASE1 Borderline Resectable Pancreatic Adenocarcinoma ClinicalTrials.gov
    Irinotecan Other Phase EARLY_PHASE1 Borderline Resectable Pancreatic Adenocarcinoma ClinicalTrials.gov
    Fluorouracil Other Phase EARLY_PHASE1 Borderline Resectable Pancreatic Adenocarcinoma ClinicalTrials.gov
    Trastuzumab Other Approved Gastric Cancer ClinicalTrials.gov
    Capecitabine Other Approved Gastric Cancer ClinicalTrials.gov
    NovoTTF-100L(P) Other Approved Gastric Cancer ClinicalTrials.gov
    Sorafenib Other Phase PHASE2 Hepatocellular Carcinoma ClinicalTrials.gov
    NovoTTF-100L(P) device Device Phase PHASE2 Hepatocellular Carcinoma ClinicalTrials.gov
    3D conformal or intensity modulated radiation therapy (IMRT) Drug Phase PHASE1 Glioblastoma, Adult ClinicalTrials.gov
    Quality of Life Assessment Other Phase PHASE2 Adult Giant Cell Glioblastoma ClinicalTrials.gov
    NovoTTF-l00A Other Phase PHASE2 Adult Giant Cell Glioblastoma ClinicalTrials.gov
    Optune (NovoTTF-100A) Other Approved Brain Cancer ClinicalTrials.gov
    Optune NovoTTF-200A System Other Phase PHASE1 High Grade Glioma ClinicalTrials.gov
    Yervoy Other Phase PHASE1 Uveal Melanoma ClinicalTrials.gov
    Opdivo Other Phase PHASE1 Uveal Melanoma ClinicalTrials.gov
    Novocure Optune Other Phase PHASE1 Uveal Melanoma ClinicalTrials.gov
    Peptides Other Phase PHASE1 Glioblastoma ClinicalTrials.gov
    Poly-ICLC Other Phase PHASE1 Glioblastoma ClinicalTrials.gov
    NovoTTF-200M device Device Phase PHASE3 Brain Metastases From Non-small Cell Lung Cancer (NSCLC) ClinicalTrials.gov
    Gadolinium Other Phase PHASE1 Glioblastoma ClinicalTrials.gov
    Nab paclitaxel Other Preclinical Locally Advanced Pancreatic Adenocarcinoma ClinicalTrials.gov
    Planned surgical resection Other Phase PHASE2 Glioblastoma ClinicalTrials.gov
    Niraparib Other Phase PHASE2 Glioblastoma ClinicalTrials.gov
    Tumor Treating Fields (TTF) Other Approved Pancreas Cancer ClinicalTrials.gov
    Stereotactic Ablative Body Radiation (SABR) Other Approved Pancreas Cancer ClinicalTrials.gov
    Optune System Other Phase PHASE2 Glioblastoma ClinicalTrials.gov
    Temozolomide (TMZ) Other Phase PHASE2 Glioblastoma ClinicalTrials.gov
    The samples described below will be collected: Other Approved Glioblastoma ClinicalTrials.gov
    Whole Brain Spectroscopy Imaging Array Mapping Layout Other Approved GBM ClinicalTrials.gov
    Placebo Other Phase PHASE3 Glioblastoma ClinicalTrials.gov
    Optune® device Device Phase PHASE3 Glioblastoma ClinicalTrials.gov
    Immune checkpoint inhibitors or docetaxel Other Phase PHASE3 Nonsmall Cell Lung Cancer ClinicalTrials.gov
    Optune® Other Approved Glioblastoma Multiforme ClinicalTrials.gov
    NovoTTF-200T(P) Other Phase PHASE2 Pancreatic Adenocarcinoma ClinicalTrials.gov
    TTF-200M and TTF-200A systems Other Phase PHASE1 Spinal Metastasis ClinicalTrials.gov
    Stereotactic Radiosurgery Procedure Phase PHASE1 Clinical Stage IV Cutaneous Melanoma AJCC v8 ClinicalTrials.gov
    Atezolizumab Other Phase PHASE2 Metastatic Pancreatic Ductal Adenocarcinoma ClinicalTrials.gov

    💼 Business Developments:

    • Partnership: Not available
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: NOVOCURE LTD
    • Ticker Symbol: NVCR

Search

News categories